Israel’s PixCell Medical (see here previously) has donated a HemoScreen 5-minute blood test device, along with hundreds of cartridges, to Ukraine, as it is ideal for “extreme point of care” use. It is also essential for emergencies and for patients … Continue reading →

Israel’s PixCell Medical (see here previously) has won the 2021 MedTech Visionary award for Best Medical Device, plus MedTech Visionary in the Field of Medical Devices for Real-Time Blood Testing. PixCell’s HemoScreen allows blood tests to be performed by anyone, … Continue reading →

Israel’s PixCell Medical (reported here previously) will be deploying its blood test analyzers in labs and emergency departments in New South Wales, Australia. PixCell’s HemoScreen low-cost portable hematology analyzer can perform a complete blood count at the point of care. … Continue reading →

Israel’s PixCell (reported here previously) has partnered with Interreg Germany-Denmark’s Changing Cancer Care (CCC) initiative. They will assess PixCell’s HemoScreen hematology analyzer for cancer patients to perform blood tests as part of their homecare oncology treatment. http://nocamels.com/2020/05/blood-test-device-home-chemo-treatments/

I reported previously (8th Apr) on Israel’s PixCell which received a multi-million grant by the EU to help advance its HemoScreen portable blood test.  The US FDA has just approved HemoScreen to sell in the USA. Meanwhile, Israel’s SightDx has … Continue reading →

Israeli blood analysis startup PixCell has been awarded a €2.5 million grant by the European commission to help commercialize its HemoScreen. http://www.globes.co.il/en/article-israeli-blood-analysis-co-pixcell-wins-25m-eu-grant-1001228031